On Monday night’s MAD MONEY show on CNBC Jim Cramer said there is noreason to wait for the J.P.Morgan Biotech conference, because healready has the stocks to play. This makes for many short-term andlong-term trades for the year, and that is why it is imprtant. He has ajump on it. His #1 biotech pick going into and coming out of theconference is what he is focusing on.
Thermo Fisher (TMO)presents at 11:00 AM EST tomorrow, and Cramer said he would buy itaround 10AM ahead of its presentation. They are the one-stop shop forall the scientific instrument and analytic needs now. TMO is his pickto buy around 10:00 AM tomorrow morning ahead of their presentation.Here are the expanded comments on TMO.
Cramerearlier picked Gilead (GILD) as one to buy going into the conference,and the street being cautious on their Myogen buyout was wrong. Myogenwas his favorite pick in biotechs in 2007. Here is the larger commentary on Gilead.
Ina call in Cramer panned Ligand Pharma (LGND) and said he wasn’t worriedabout a small portion of insider ownership in Genentech (DNA) and Amgen(AMGN) because they are so huge. Cramer did not re-mention Savient (SVNT), his #2 runner-up for his top speculative stocks in 2007.
OVERLOOKED IPO OF 2006
Crameralso wanted to review some IPO’s of 2006 that didn’t work out well atall to see if they were overlooked. His #1 overlooked IPO is Optium(OPTM). Because of all the telecom equipment providers this has beenlumped in with the bad ones. It came public in October 2006 and it is asupplier of Fiber to the home and Triple Play. Here are the rest of his comments.
Jon C. Ogg
January 9, 2007
Top Gaining Stocks
Top Losing Stocks